Table 1 Baseline characteristics of 3256 study subjects.

From: Association of long-term use of low-dose aspirin with Helicobacter pylori infection and effect on recurrence rate

Dependent variable

HP (+) (n = 1733)

HP (−) (n = 1523)

t/Z/χ2

P value

Age [years]

52.1 ± 9.2

50.4 ± 8.9

3.166

0.002

Female [case (%)]

794 (45.8)

631 (41.4)

6.628

0.01

BMI (kg/m2)

24.59 ± 3.11

24.36 ± 3.01

2.135

0.033

Long-term smoking [cases (%)]

144 (8.3)

128 (8.4)

0.01

0.922

Fatty liver [cases (%)]

71 (4.1)

52 (3.4)

1.039

0.308

Essential hypertension [cases (%)]

1389 (80.2)

1207 (79.3)

0.405

0.541

Heart disease [cases (%)]

204 (11.8)

193 (12.7)

0.614

0.453

Cerebrovascular diseases [cases (%)]

81 (4.7)

72 (4.7)

0.005

0.943

Peripheral artery disease [cases (%)]

57 (3.3)

48 (3.2)

0.049

0.843

Others [example (%)]

46 (2.7)

41 (2.8)

0.004

0.947

TG (mmol/L)

1.93 ± 1.17

1.92 ± 1.21

0.204

0.838

TC (mmol/L)

5.06 ± 0.94

5.07 ± 0.91

0.416

0.677

HDL-C (mmol/L)

1.47 ± 0.35

1.44 ± 0.34

0.343

0.641

LDL-C (mmol/L)

2.36 ± 0.61

2.29 ± 0.57

3.174

0.002

UA (µmol/L)

361.21 ± 90.41

359.87 ± 92.77

1.083

0.293

FBG (mmol/L)

5.35 ± 0.53

5.22 ± 0.52

2.519

0.024

Hcy (µmol/L)

19.33 ± 5.56

20.17 ± 4.79

0.328

0.531

Long-term use of aspirin [cases (%)]

674 (38.9)

517 (33.9)

8.548

0.003

 1–2 years [case (%)]

103 (15.3)

92 (17.8)

1.35

0.269

 ≥ 2–<5 years [case (%)]

245 (36.4)

181 (35.0)

0.229

0.669

 ≥ 5 years [case (%)]

326 (48.4)

244 (47.2)

1.161

0.726

Statins [case (%)]

698 (40.3)

621 (40.8)

0.083

0.775

Endothelin B-receptor blockers [case (%)]

303 (17.5)

259 (17)

0.13

0.745

Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin-receptor blockers (ARB) [case (%)]

836 (48.2)

754 (49.5)

0.521

0.482

Aldosterone receptor antagonists [case (%)]

539 (31.1)

482 (31.6)

0.112

0.762

Thiazide diuretics [case (%)]

219 (12.6)

182 (11.9)

0.354

0.552

Clopidogrel [case (%)]

175 (10.1)

138 (9.1)

1.003

0.341

  1. Significant values are given in bold.